Confrontation Phenotypes and Genotypes of Epithelial Odontogenic Tumors of the Jaws (TEIOS)

April 23, 2015 updated by: Assistance Publique - Hôpitaux de Paris

Confrontation Phenotypic (Clinical, Radiological, Histological) and Genotypic Epithelial Odontogenic Tumors Isolated or Syndromic Jaws

Systematically compare the phenotype and genotype of epithelial odontogenic tumors in children and adults with a clinical, radiographic, pathologic and molecular level.

Either:

establish an observatory of this multidisciplinary tumor establish a tumor bank annotated scale unparalleled testing pathophysiological hypotheses search for prognostic factors.

Study Overview

Status

Completed

Detailed Description

This is an observational study with retrospective and prospective parts. In retrospective part be included the Patients followed between 1992 and January 2011.

In prospective part will follow the Patients will be included after the starting of study.

There are 2 centers :

  1. st center is in the service of Stomatology and Maxillofacial Surgery in the Pitie Salpetriere Hospital.
  2. nd center is in the service of Maxillofacial Surgery in hospital Armand Trousseau.

Number of patients include in the part retrospective :

Center N°1-300adults Center N°2-90childrens

Number of patients include in the part prospective :

Center N°1- 90 Center N°2- 30

Duration of study is 3 years Duration of inclusion is 32 months Each patient will be followed for 4 months and for further up to 3 years from the first patient included.

We envision a next circuit : obtaining consent, preoperative consultation,surgery, postoperative consultation N°1, postoperative consultation N°2, genetics consultation and monitoring of patients in 6;12;18;24 months from surgery of tumor and limited in 3 years from th 1st patient included.

Study Type

Observational

Enrollment (Actual)

319

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75013
        • Stomatologie et Chirurgie Maxillofaciale - Pitie Salpetriere

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patient with an osteolytic lesion of the jaws resulting of an epithelial odontogenic tumor

Description

Inclusion criteria

  1. Patient with an osteolytic lesion of the jaws
  2. Patient with epithelial odontogenic tumor:

    keratocysts ameloblastoma Pindborg tumor or calcifying (ESWT) Epidermoid (Squamous Odontogenic Tumor SOT) Clear cell (Clear Odontogenic Tumor Cells CCOT)

  3. Patient monitoring in the period 1992 to January 2011 at the Trousseau Hospital (children) or at the Pitie Salpetriere (adult)
  4. Patient aged 5 years or more
  5. Adult patient who had signed informed consent
  6. Holders of parental authority of minor patient were informed and signed consent

Non inclusion criteria

  1. Patient with an osteolytic lesion of dental origin inflammatory (adjacent teeth decayed, non-living mortified)
  2. Patient with a cyst fissure (nasopalatine, symphyseal or globulomaxillary)
  3. Patient with arteriovenous malformation, vascular
  4. Patient with cons-indication to MRI
  5. Patient not affiliated with a social security scheme (beneficiary or assignee)
  6. Pregnant woman
  7. Patient in his history of hypersensitivity to salts of gadolinium
  8. Patient receiving a measure of legal protection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
epithelial odontogenic tumours

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Phenotypic and genotypic lines connected to the epithelial odontogenic tumours
Time Frame: Month 24 from the surgery date

In particular, to define the link between the genotype PTCH1, the size of the tumor, its osteolytic character and the predictive factors of recurrence.

Data collection at M6, M12, M18, M24 from the surgery date

Month 24 from the surgery date

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Blandine Ruhin, MD, PhD, Assistance Publique - Hôpitaux de Paris

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (ACTUAL)

September 1, 2014

Study Completion (ACTUAL)

September 1, 2014

Study Registration Dates

First Submitted

June 13, 2014

First Submitted That Met QC Criteria

June 17, 2014

First Posted (ESTIMATE)

June 19, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

April 24, 2015

Last Update Submitted That Met QC Criteria

April 23, 2015

Last Verified

April 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • P081259

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Epithelial Odontogenic Tumours

3
Subscribe